ArticleFrontiers in pharmacology2021

Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial.

Jin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.